MedPath

A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile childre

Completed
Conditions
Fever
Signs and Symptoms
Registration Number
ISRCTN21521538
Lead Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

Children presenting in the BRI children's emergency department with fever.
1. Age 6 months - 16 years
2. Children with a temperature of 38.0 degrees C or more will be eligible

Exclusion Criteria

1. Those admitted directly to resuscitation by ambulance or those transferred there following initial clinical assessment
2. Those eligible for recruitment in any other study running concurrently or those who have been recruited to a simultaneous study of children's fever
3. Prior administration that will interfere with randomisation: paracetamol within the last six hours or ibuprofen within the last six hours
4. Allergy to either study drug
5. Likely dehydration, cellulitis or skin infection, concomitant warfarin or heparin, chronic illness likely to interfere with drug metabolism (kidney or liver disease), immunosuppression, HIV+, concomitant chemo or radiotherapy, organ or bone marrow transplant recipient, immunosuppressive therapy in the last three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The child's temperature one hour after study antipyretics
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath